15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 21.6% per year over the past 5 years.
Financial health
Total debt ($49M) exceeds cash ($46M); net debt is $3M.
Total debt has grown slower than revenue (18.2% vs 21.6% per year).
Operating income covered interest expense -10.1× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 1.9 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$37M
-$26M
61.4%
-65.4%
-91.1%
-26.1%
-$24M
$49M
$46M
2024
$31M
-$19M
60.9%
-62.9%
-74.5%
-48.3%
-$9M
—
$20M
2023
$24M
-$22M
56.8%
-93.7%
-104.3%
-51.8%
-$14M
$10M
$23M
2022
$21M
-$16M
65.8%
-79.5%
-44.6%
-29.6%
-$16M
$10M
$28M
2021
—
-$14M
—
—
-29.5%
-22.0%
-$13M
$10M
$54M
2020
—
-$7M
—
—
-285.3%
-23.0%
-$8M
$21M
$20M
2019
—
-$6M
—
—
-120.8%
-46.4%
-$3M
$2M
$6M
2018
—
-$6M
—
—
-408.2%
-78.4%
-$5M
$3M
$3M
2017
—
-$7M
—
—
-123.0%
-51.6%
-$6M
$5M
$9M
2016
—
-$8M
—
—
1067.3%
-109.0%
-$6M
$4M
$3M
2015
—
-$8M
—
—
426.5%
-85.0%
—
$8M
$5M
2014
—
-$5M
—
—
4509.8%
-33.8%
-$7M
$11M
$9M
2013
—
-$7M
—
—
103.7%
-90.0%
-$8M
—
$4M
2012
—
-$6M
—
—
74.7%
-105.9%
-$8M
—
$2M
2011
—
-$8M
—
—
38.1%
-274.3%
-$6M
—
$145478
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$11M
-$11M
61.7%
-94.2%
-105.2%
-13.1%
-$7M
$50M
$29M
Mar '26
$12M
-$10M
64.0%
-69.9%
-50.7%
-10.2%
-$9M
$50M
$36M
Dec '25
$10M
-$8M
61.5%
-67.7%
-27.8%
-8.0%
-$12M
$49M
$46M
Sep '25
$9M
-$6M
63.2%
-59.5%
-37.1%
-9.8%
-$3M
$29M
$38M
Jun '25
$9M
-$6M
60.3%
-61.6%
-29.6%
-9.3%
-$3M
$29M
$42M
Mar '25
$8M
-$6M
60.5%
-72.6%
-30.1%
-20.0%
-$6M
—
$12M
Dec '24
$8M
-$5M
61.3%
-72.5%
-21.2%
-13.7%
-$2M
—
$20M
Sep '24
$8M
-$5M
59.7%
-63.5%
-17.2%
-12.4%
-$1M
—
$22M
Jun '24
$8M
-$4M
63.5%
-60.1%
-13.7%
-8.4%
-$3M
$10M
$33M
Mar '24
$8M
-$4M
59.2%
-55.2%
-12.0%
-7.7%
-$4M
$10M
$35M
Dec '23
$7M
-$5M
58.9%
-69.1%
-21.8%
-10.8%
-$1M
$10M
$23M
Sep '23
$6M
-$5M
56.8%
-85.0%
-20.0%
-11.0%
-$2M
$10M
$24M
Jun '23
$6M
-$7M
52.5%
-119.8%
-25.7%
-14.8%
-$5M
$10M
$26M
Mar '23
$5M
-$6M
58.9%
-105.1%
-17.2%
-11.2%
-$6M
$10M
$22M
Dec '22
$5M
-$4M
65.1%
-86.4%
-11.9%
-7.9%
-$3M
$10M
$28M
Sep '22
$5M
-$4M
71.5%
-73.7%
-9.5%
-6.6%
-$4M
$10M
$19M
Jun '22
$5M
-$4M
62.6%
-80.8%
-10.0%
-7.1%
-$5M
$10M
$24M
Mar '22
$5M
-$4M
64.2%
-76.8%
-8.7%
-6.4%
-$4M
$10M
$50M
Dec '21
—
-$4M
—
—
-8.5%
-6.3%
-$4M
$10M
$54M
Sep '21
$5M
-$4M
66.5%
-83.2%
-9.0%
-5.8%
-$3M
$18M
$58M
Valuation over time
How the market has priced CLPT against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 12.4× (Mar '23) to 11.6× (Sep '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is CLPT growing its revenue and profit?
Over the past 5 years, ClearPoint Neuro, Inc.'s revenue has grown 21.6% per year. These are computed facts, not advice.
How much debt does CLPT have?
As of FY2025, ClearPoint Neuro, Inc. reported $49M of total debt against $46M of cash; operating income covered interest expense -10.1×.
What is CLPT's profit margin?
In FY2025, gross margin was 61.4%, operating margin -65.4%, and net margin -69.1%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.